Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Clinical study on changes of tongue coating cicrobiota in patients with coronary heart disease and angina pectoris of qi-stagnation and blood stasis syndrome treated with Xuefu Zhuyu Capsule
Hits 260  Download times 31  Received:November 07, 2025  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2026.02.04
Key Words   coronary heart disease-related angina pectoris;qi-stagnation and blood-stasis syndrome;Xuefu Zhuyu Capsule;tongue coating microbiota
Author NameAffiliationE-mail
ZHANG Qian Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HE Yuanyuan Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CHEN Wenli Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Shuo Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
GAO Shan Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
LI Lin Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
NI Tongyao Shanghai Medical Emergency Center, Shanghai 200233, China 15822309511@163.com 
YU Chunquan Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China ycqtjutcm@foxmail.com 
Abstract
    [Objective]This study employed 16S rDNA sequencing technology to investigate the effects of Xuefu Zhuyu Capsules on the tongue coating microbiota in patients with coronary heart disease-related angina pectoris(qi-stagnation and blood-stasis syndrome), providing experimental evidence for its clinical application.[Methods]A prospective, multicenter clinical trial design was adopted. Patients with coronary heart disease and angina pectoris of qi-stagnation and blood stasis pattern were divided into the Xuefu Zhuyu Capsule treatment group(Xuefu Zhuyu Capsules combined with conventional Western medicine treatment), the conventional Western medicine treatment group, and a healthy control group, with 30 cases in each group. Tongue coating samples were collected at 0 week and 8 week from the two treatment groups, and at week 0 from the healthy group. 16S rDNA amplicon sequencing was used to profile the tongue coating microbiota in patients with coronary heart disease and angina pectoris of qi-stagnation and blood stasis syndrome, in order to identify disease-related taxa and key microbiota modulated by Xuefu Zhuyu Capsules.[Results]Compared with healthy individuals, patients showed increased enrichment of Proteobacteria and Actinobacteria, which decreased after Xuefu Zhuyu Capsules treatment. Conversely, reduced enrichment of Bacteroidetes, Firmicutes and Fusobacteria was observed, with their abundance increasing post-treatment. LEfSe analysis identified Roseburia, Micrococcaceae, Micrococcales, Actinobacteria and Actinomyces as biomarkers regulated by Xuefu Zhuyu Capsules.[Conclusion]Xuefu Zhuyu Capsules alleviate clinical symptoms in patients with coronary heart disease and angina pectoris(qi-stagnation and blood stasis syndrome), accompanied by tongue coating flora structural alterations and suggested the flora may serve as a potential microcosmic indicator for evaluating the drug's efficacy in this condition.

You are the 4053565 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.